PGEN Earnings & Financial Statements
Precigen, Inc.
$7.54
-$0.01(-0.13%)
52
Overall
40
Value
66
Tech
50
Quality
Market Cap
$2.70B
Volume
4.14M
52W Range
$2.99 - $8.98
Target Price
$13.67
PGEN earnings and financial statements: Precigen, Inc.'s income statement, balance sheet and cash flow statement, annual and quarterly.
PGEN Annual Financial Statements
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | $9.68M | $3.92M | - | $26.91M | $14.27M |
| Cost of revenue | $4.82M | $4.27M | - | - | $5.75M |
| Operating income | -$110.51M | -$135.03M | -$12.56M | -$13.24M | $14.27M |
| EBITDA | -$243.22M | -$123.50M | -$89.17M | -$68.16M | -$66.72M |
| Net income | -$250.64M | -$126.23M | -$95.90M | $28.32M | -$92.17M |
| EPS (diluted) | $-1.37 | $-0.47 | $-0.39 | $0.14 | $-0.47 |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total assets | $155.50M | $145.27M | $151.04M | $215.98M | $359.86M |
| Total liabilities | $134.59M | $78.53M | $32.55M | $89.72M | $252.51M |
| Shareholders’ equity | $20.91M | $38.51M | $118.50M | $126.26M | $107.35M |
| Cash and equivalents | $30.23M | $29.52M | $7.58M | $4.86M | $36.42M |
| Long-term debt | $97.15M | $4.55M | $5.89M | $6.99M | $188.63M |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating cash flow | -$87.83M | -$68.17M | -$66.93M | -$65.05M | -$55.77M |
| Capital expenditure | -$2.00M | -$8.52M | -$1.54M | -$4.92M | -$7.25M |
| Free cash flow | -$89.83M | -$76.76M | -$68.47M | -$69.97M | -$63.02M |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | PGEN | $7.54 | -0.1% | 4.14M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |